Nov 10, 2019

Grand Elysée Hamburg
Rothenbaumchaussee 10 | 20148 Hamburg, Germany








About China Focus

China Focus brings together investors, pharma leaders, and biotech & Medtech innovators from China and around the world for an exclusive partnering event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations. The pharma market in China grew to ~Rmb1,558bn (US$226bn) in 2018, at a CAGR of 10% in 2013-18, becoming the 2nd largest pharma market in the world. As the youngest member of ICH (International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use), China joined with the least experience but holding the promise to bring domestic clinical trials to world standard and open its market. There will be new revenues for innovative therapeutics and more business development opportunities for global players. The current U.S.-China relationship and CFIUS regulations in the U.S. derived interest from some Chinese investors to the European market.

Following the successful China Focus@Europe Vienna in March 2019,we have received increasing interest from Chinese companies to expand business development activities in European countries. In order to better connect Chinese companies and European markets, China Focus comes to Europe again this November, featuring keynote speech, panel discussion, Chinese companies showcase, 1-on-1 meeting, and company presentation (Pitch & Match).

Who should attend


  • Investors (VC, PE, investment bank, etc.)
  • Life science innovators and entrepreneurs
  • Biotech & big pharma
  • Medtech (device and diagnostics) manufacturers and distributors
  • Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
  • Healthcare providers

Main topics


  • NMPA (previously CFDA) regulatory reforms and new opportunities for biotech & pharma
  • Opportunities and barriers for new Chinese players entering the market
  • New IPO opportunities and the impact on the valuation of biotech companies: HKEX and STAR Market
  • European biotech space: how is it unique?
  • Current and future hot spots in modality and therapeutic area – how can China and Europe join forces?

What you can get


  • Learn about Chinese life science and healthcare industry
  • Hear the latest Chinese regulatory reforms and implications
  • Meet with the decision makers in the industry
  • Initiate business conversations that otherwise difficult to start
at Previous China Focus Events


Time Plenary session (Room Speicherstadt II)
9:00 AM – 9:40 AM Opening Remarks
Keynote: China’s Role in Healthcare investment and partnership in Europe
    Stephen Sunderland – Partner, L.E.K. Consulting
9:40 AM – 10:40 AM Panel 1: Regulatory reforms in China and the impact on cross-border collaborations
10:40 AM – 11:00 AM Coffee Break
11:00 AM – 12:00 PM Panel 2: Hot spot in modality and therapeutics area – how can China and Europe join forces?
Moderator: Chenchao Liu – Founder & CEO of Silreal; Co-founder & Chairman of Sino-European Digital Health Club
    James Huang – Managing Partner, KPCB China
12:00 PM – 1:30 PM Lunch break
1:30 PM – 2:30 PM Panel 3: European pharmaceutical pricing regulation – opportunities and barriers for new Chinese players entering the market
Moderator: Sebastian Gensior – Founder of Sino European Pharma Forum; Managing Director of Global Health Access Solutions
    Marcus Guardian – Chief Operating Officer, EUnetHTA
    Peter Hertzman – Founder and Principal Consultant – Health Access Agency
    Michal Czarnuch – Partner, Domanski Zakrzewski Palinka
2:30 PM – 2:50 PM Featured Talk: New IPO opportunities with HKEX and STAR market and the impact on the valuation of biotech companies
2:50 PM – 3:10 PM Coffee Break
3:10 PM – 4:00 PM Chinese company showcase
4:00 PM – 5:00 PM Panel 4: Recipe for a successful cross-border partnership
Moderator: Echo Hindle-Yang – CEO, MSQ Ventures
    Jürgen Gamer – VP Business Development, Apogenix GmbH


Stephen Sunderland


L.E.K. Consulting

James Huang

Managing Partner

KPCB China

Yan Song

Founder and CEO

Link Health Group

Sebastian Gensior

Founder, Sino-European Pharma Forum (SEPF)

Managing Director, Global Health Access Solutions

Chenchao Liu

Co-founder & Chairman, Sino-European Digital Health Club

Founder & CEO, Silreal

Marcus Guardian

Chief Operating Officer

European Network of Health Technology Assessment (EUnetHTA)

Peter Hertzman

Founder and Principal Consultant

Health Access Agency

Michal Czarnuch


Domanski Zakrzewski Palinka

Echo Hindle-Yang


MSQ Ventures

Jürgen Gamer

VP Business Development

Apogenix GmbH

Andy Li

CEO and President

BioSense Global LLC

Sally Zheng

Managing Partner

Global Alpha Ventures


Chinese Companies and Investors


Executive Level Attendees

One-to-one meetings

apply to present
Get an audience list from China’s top-tier pharmaceutical companies and investors in advance. Pitch your company and secure one-on-one meetings with the right audience
Learn about opportunities from the rising healthcare market, innovation and investment trend in China from industry leaders
Qualified investors can request a complimentary registration
Member of the press can request for a complimentary regisitration

Download Sample Attendee List from past China Focus events

Download Program from past China Focus events
Sponsor & Partner

Boost company exposure and brand awareness through digital and onsite visibility

Receive consultation service and priority in the partnering process

Position your company as a leader within the life science industry through sponsorship

Customizable sponsorship packages




15 + 4 =

Registration, Sponsorship and Collaboration (China)

Youwen (Allen) Dai Registration, Sponsorship and Collaboration (U.S. and Europe) Xinxin Li Speaker, Group Delegation and Presenting Companies Han Yan General Inquiries +1-832-497-2220


Grand Elysée Hamburg
Rothenbaumchaussee 10
20148 Hamburg, Germany

Phone: +49 40 41412-780

Fax: +49 40 41412-779